Approval · Notice of Compliance 7950 · 2006
ANANDRON: Notice of Compliance 7950
Issued May 11, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7950
- Date
- May 11, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Nonsteroidal antiandrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANANDRON | 02221861 | Dormant |
| ANANDRON | 02241376 | — |
Medicinal ingredients
- NILUTAMIDE 50 MG per TAB
- NILUTAMIDE 150 MG per TAB